No definition available.
Immunodeficiency with predominantly antibody defects
DOID EFO Endpoint Browser PheWeb
D3_IMMUDEFANTIBODY
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
932 |
4. Check minimum number of eventsNone |
932 |
5. Include endpoints |
959 |
6. Filter based on genotype QC (FinnGen only) |
959 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80-D89
- Name in latin
- Deficientia immunalis praecipue cum vitiis anticorporum
Similar endpoints
↥List of similar endpoints to
Immunodeficiency with predominantly antibody defects
based on the number of shared cases.
Similar with more cases:
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4354 | 2534 | 1806 |
| Only index persons | 3907 | 2323 | 1584 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.07 | 0.05 |
| Only index persons | 0.08 | 0.09 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 41.53 | 44.86 | 36.81 |
| Only index persons | 41.99 | 45.45 | 36.90 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 959 | 631 | 328 |
| Unadjusted period prevalence (%) | 0.19 | 0.22 | 0.14 |
| Median age at first event (years) | 48.60 | 47.78 | 50.17 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 872
- Matched controls
- 8717
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
323.0
329
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
277.3
251
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
245.8
224
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
2764.7
242.3
223
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
229.6
210
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
204.4
188
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
22.0
156.6
237
145
ZX120
NOMESCO Finland
Intravenous
12.0
156.2
318
399
H02AB06
ATC
prednisolone; systemic
6.7
140.7
663
2792
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
1551.4
139.5
132
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.3
137.0
606
2319
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
16.5
130.0
219
173
J01MA12
ATC
levofloxacin; systemic
7.4
128.5
371
796
J01MA14
ATC
moxifloxacin; systemic
10.6
123.9
264
343
J18.9
ICD-10 Finland
Pneumonia, unspecified
6.6
123.0
394
963
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
119.6
112
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
10.6
118.8
252
322
6BA02
NOMESCO Finland
NA
264.4
114.8
115
5
WW200
NOMESCO Finland
Immunization
22.4
114.8
171
94
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
16.0
101.7
172
132
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
21.1
101.0
153
87
TPH04
NOMESCO Finland
Cathetrisation of vein
5.5
98.5
365
1008
TDM10
NOMESCO Finland
Puncture of maxillary antrum
13.4
93.5
171
156
R50.9
ICD-10 Finland
Fever, unspecified
5.9
88.9
294
694
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
10.4
88.1
184
218
J47
ICD-10 Finland
Bronchiectasis
32.9
87.0
115
40
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.0
86.8
277
623
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
9.0
83.9
192
266
H02AB07
ATC
prednisone; oral
5.7
80.4
270
638
J01.0
ICD-10 Finland
Acute maxillary sinusitis
4.4
79.8
375
1268
J45.1
ICD-10 Finland
Nonallergic asthma
8.4
78.4
187
275
J45.9
ICD-10 Finland
Asthma, unspecified
4.9
77.5
310
886
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.1
75.1
390
1427
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.2
74.1
178
263
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
13.0
74.1
136
122
R03DC03
ATC
montelukast; oral
4.7
73.3
301
875
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.6
72.4
310
939
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.8
71.3
286
808
J01FA06
ATC
roxithromycin; oral
3.6
69.4
505
2410
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.7
67.3
404
1634
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.0
67.3
208
434
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.3
66.6
195
379
Z3231
NOMESCO Finland
Registered nurse
3.7
65.0
389
1560
R03BA02
ATC
budesonide; inhalant
4.2
61.9
286
908
TGC00
NOMESCO Finland
Bronchial lavation
16.2
61.1
101
70
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.4
60.5
154
244
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.1
60.4
160
269
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.3
59.3
602
3507
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
59.0
56
*
XW000
NOMESCO Finland
Bone marrow biopsy
11.6
58.8
113
110
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.5
57.3
144
223
C01CA24
ATC
epinephrine; parenteral
6.0
53.5
161
318
R03AC02
ATC
salbutamol; inhalant
3.1
53.4
589
3507
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.0
52.7
542
3066
J01FA10
ATC
azithromycin; systemic
3.1
50.9
646
4159
J01MA02
ATC
ciprofloxacin; systemic
3.0
50.7
426
2084
R03BB04
ATC
tiotropium bromide; inhalant
5.4
50.4
165
359
Z2221
NOMESCO Finland
Medical doctor
3.2
50.0
362
1596
H02AB04
ATC
methylprednisolone; systemic
4.1
49.8
226
687
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.1
49.3
220
658
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
48.4
46
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
9.4
47.9
103
123
Z01.8
ICD-10 Finland
Other specified special examinations
3.3
47.1
297
1174
H02AB09
ATC
hydrocortisone; systemic
11.3
47.0
91
89
J01FF01
ATC
clindamycin; systemic
3.1
46.9
339
1476
C03CA01
ATC
furosemide; systemic
3.5
46.5
270
1001
Z3226
NOMESCO Finland
Physiotherapist
3.5
45.8
265
977
J32.4
ICD-10 Finland
Chronic pansinusitis
20.1
45.7
69
37
R03AC12
ATC
salmeterol; inhalant
8.2
45.1
105
143
J01FA09
ATC
clarithromycin; systemic
2.9
44.5
388
1897
JN4BD
NOMESCO Finland
Extensive body CT
4.6
43.4
167
428
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
43.1
41
*
R01AD09
ATC
mometasone; nasal
2.7
42.6
505
2948
A07AA02
ATC
nystatin; oral
6.6
42.5
115
195
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
42.3
407
2093
J46
ICD-10 Finland
Status asthmaticus
10.3
42.1
85
90
R4110
NOMESCO Finland
Physiotherapy
3.0
42.1
324
1449
A03FA01
ATC
metoclopramide; systemic, rectal
3.2
41.3
263
1030
R03BA05
ATC
fluticasone; inhalant
3.2
41.1
258
1000
R06.0
ICD-10 Finland
Dyspnoea
3.1
41.0
279
1143
L03AA02
ATC
filgrastim; parenteral
10.9
40.8
80
80
ZX108
NOMESCO Finland
Inhalation
36.8
40.8
52
15
R01AD08
ATC
fluticasone; nasal
2.8
40.8
355
1707
ZXA10
NOMESCO Finland
Bilateral
3.4
40.8
237
866
R03BB01
ATC
ipratropium bromide; inhalant
9.7
40.6
85
96
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.0
40.5
142
329
J05AB11
ATC
valaciclovir; oral
3.7
40.0
200
648
R03AC13
ATC
formoterol; inhalant
6.9
39.4
103
166
R03DA04
ATC
theophylline; systemic, rectal
7.1
38.9
100
157
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
38.8
37
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
38.7
190
604
J01FA15
ATC
telithromycin; oral
4.0
38.7
173
508
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.8
38.6
334
1586
M05BA04
ATC
alendronic acid; oral
5.3
37.2
122
261
WW500
NOMESCO Finland
Blood transfusion
7.9
37.2
88
122
J01DB01
ATC
cefalexin; oral
3.4
36.4
772
6068
J01AA02
ATC
doxycycline; systemic
2.9
36.4
719
5385
N02AX02
ATC
tramadol; systemic, rectal
2.5
36.3
424
2372
R03AK07
ATC
formoterol and budesonide; inhalant
3.1
36.2
238
940
A02BC02
ATC
pantoprazole; systemic
2.5
36.1
603
4084
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.5
35.8
112
227
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
25.2
35.7
50
21
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.4
35.4
98
170
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
361.0
35.2
35
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.2
35.2
221
843
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
19.4
34.8
53
29
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
34.4
318
1548
R01AD05
ATC
budesonide; nasal
4.3
34.3
137
359
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
34.3
105
207
ZXE00
NOMESCO Finland
One hour or less
2.5
34.2
426
2441
TAB00
NOMESCO Finland
Lumbar puncture
6.2
34.1
96
170
XG410
NOMESCO Finland
Flow-volume spirometry
7.2
33.8
85
129
J02AC01
ATC
fluconazole; systemic
2.4
33.6
447
2640
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
33.5
206
771
GD1AD
NOMESCO Finland
Thorax CT examination
7.2
33.2
83
125
R05
ICD-10 Finland
Cough
2.9
33.1
239
996
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
32.9
138
379
R03BA08
ATC
ciclesonide; inhalant
4.3
32.6
131
345
J45.8
ICD-10 Finland
Mixed asthma
7.7
32.6
78
110
H04.10
ICD-10 Finland
Dry eye syndrome
3.9
32.4
144
416
UJF32
NOMESCO Finland
Coloscopy
2.7
32.2
275
1270
A41.9
ICD-10 Finland
Sepsis, unspecified
7.9
32.1
75
102
UJF30
NOMESCO Finland
Ileoscopy through colon
4.0
32.1
140
398
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
31.9
136
378
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
31.4
30
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
27.5
30.8
42
16
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
8.9
30.8
67
81
XQ800
NOMESCO Finland
Prick test
3.9
30.7
139
407
M04AA01
ATC
allopurinol; systemic
3.9
30.5
137
398
N03AX16
ATC
pregabalin; oral
2.6
29.4
257
1191
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
29.3
28
*
J01DA06
ATC
[U] cefuroxime; systemic
3.0
29.0
190
736
N02AA05
ATC
oxycodone; systemic
3.4
28.9
159
543
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
5.4
28.8
90
181
R03AK08
ATC
formoterol and beclometasone; inhalant
6.3
28.7
79
136
R03DC01
ATC
zafirlukast; oral
14.0
28.5
49
37
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
28.3
27
*
R01AD12
ATC
fluticasone furoate; nasal
2.3
28.1
345
1904
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.3
28.0
386
2254
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
16.3
27.9
45
29
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
14.1
27.5
47
35
Z2446
NOMESCO Finland
Social worker
4.0
27.1
116
322
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.6
27.1
53
53
J31.0
ICD-10 Finland
Chronic rhinitis
3.9
26.9
120
345
ZXA00
NOMESCO Finland
Right side
2.5
26.9
272
1354
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
17.6
26.9
42
25
WZC30
NOMESCO Finland
Teaching
3.1
26.7
165
608
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
26.6
385
2285
ZX112
NOMESCO Finland
Subcutaneous
8.9
26.4
57
68
J05AB01
ATC
aciclovir; systemic
2.6
26.4
240
1126
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
10.0
26.3
53
56
R03AK11
ATC
formoterol and fluticasone; inhalant
8.8
26.2
57
69
L04AX01
ATC
azathioprine; systemic
4.9
26.0
89
198
R03AC03
ATC
terbutaline; inhalant
3.0
26.0
173
671
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.5
25.4
94
227
R03BA01
ATC
beclometasone; inhalant
2.9
25.4
174
689
L04AA06
ATC
mycophenolic acid; systemic
10.7
25.3
49
48
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.9
25.2
172
677
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
25.1
24
*
A01AB09
ATC
miconazole; local oral
3.7
25.0
117
350
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
28.5
24.6
33
12
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.8
24.6
86
196
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
24.5
167
657
J20
ICD-10 Finland
Acute bronchitis
3.4
24.4
128
420
ZXD05
NOMESCO Finland
Urgent procedure
2.2
24.3
315
1755
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.4
24.2
128
422
1XC02
NOMESCO Finland
NA
23.5
24.0
34
15
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
8.0
23.9
55
73
A04AA01
ATC
ondansetron; systemic, rectal
4.0
23.7
99
268
R06AE07
ATC
cetirizine; oral
2.1
23.6
445
2910
A02BC05
ATC
esomeprazole; systemic
2.1
23.6
383
2352
J01DA01
ATC
[U] cefalexin; systemic
2.1
23.6
580
4233
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
23.5
371
2249
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.8
23.4
60
94
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
22.8
23.1
33
15
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.9
22.9
58
89
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
11.2
22.8
43
40
P01AB01
ATC
metronidazole; oral, rectal
2.1
22.5
386
2412
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.8
22.5
78
176
R01BA52
ATC
pseudoephedrine, combinations; oral
2.2
22.3
316
1818
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
22.1
22.3
32
15
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.9
22.2
97
273
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
22.1
122
413
2790B
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI A]
+∞
22.0
21
*
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
22.0
21
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
21.9
106
325
J45
ICD-10 Finland
Asthma
3.1
21.7
128
456
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.2
21.6
53
78
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
21.6
150
595
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
5.4
21.5
66
130
D70.89
ICD-10 Finland
Neutropenic splenomegaly
12.8
21.5
38
31
S01GX01
ATC
cromoglicic acid; ophthalmic
2.3
21.4
231
1168
SPAT1262
SPAT
Handing over of treatment supplies
2.6
21.3
182
811
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
21.3
341
2057
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
7.4
21.2
51
73
D64.9
ICD-10 Finland
Anaemia, unspecified
3.5
21.1
104
323
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.4
21.1
109
352
A02BC01
ATC
omeprazole; systemic
2.2
20.9
262
1418
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
20.9
20
*
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.0
20.9
59
105
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.7
20.9
45
54
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
214.9
20.7
21
*
ZY010
NOMESCO Finland
Hospital outpatient
4.1
20.6
84
222
L03AA13
ATC
pegfilgrastim; parenteral
5.4
20.6
63
124
JN4AD
NOMESCO Finland
Body CT examination
3.7
20.3
94
278
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
20.2
127
470
J01DA08
ATC
[U] cefaclor; oral
2.7
20.1
148
606
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.3
20.1
108
359
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.8
20.0
68
150
XA800
NOMESCO Finland
Neuropsychological investigation
4.3
20.0
77
193
Z3229
NOMESCO Finland
Other healthcare associate professional
3.3
20.0
110
370
WX002
NOMESCO Finland
Sedation and analgesia
2.4
19.9
198
957
N03AX12
ATC
gabapentin; oral
2.5
19.9
169
752
N02BE01
ATC
paracetamol; systemic, rectal
2.3
19.8
745
6232
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
9.7
19.8
40
43
A46
ICD-10 Finland
Erysipelas
2.8
19.7
135
527
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.8
19.6
139
555
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
22.2
19.6
28
13
ZXA05
NOMESCO Finland
Left side
2.2
19.6
233
1225
N05CF01
ATC
zopiclone; oral
2.1
19.5
289
1671
127
Kela drug reimbursment
Transplant complication
8.9
19.3
41
48
R81
ICPC
Pneumonia
5.7
19.2
56
104
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
23.2
19.1
27
12
ZX121
NOMESCO Finland
Central venous catheter
23.2
19.1
27
12
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.0
19.1
121
449
E0000UV
ATC
NA
2.0
19.0
384
2505
N05BA01
ATC
diazepam; systemic, rectal
2.7
19.0
142
586
B29
ICPC
Lymph/immune mech sympt/complt other
35.2
19.0
24
7
J32.1
ICD-10 Finland
Chronic frontal sinusitis
35.2
19.0
24
7
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
19.0
295
1740
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
19.0
124
470
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
18.9
160
706
J01.4
ICD-10 Finland
Acute pansinusitis
16.3
18.9
30
19
2790C
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]
+∞
18.8
18
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
18.8
18
*
P01BA02
ATC
hydroxychloroquine; oral
3.1
18.7
109
381
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
18.4
132
530
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
6.0
18.4
51
89
N06AX21
ATC
duloxetine; oral
2.7
18.3
132
533
A41.8
ICD-10 Finland
Other specified sepsis
10.1
18.3
36
37
R06AE09
ATC
levocetirizine; oral
2.4
18.1
171
801
ZX114
NOMESCO Finland
Intramuscular
7.7
18.1
42
57
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.5
18.1
89
276
A02BC03
ATC
lansoprazole; oral
2.1
18.0
264
1511
R51.80
ICD-10 Finland
Headache
2.4
17.8
169
793
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.0
17.8
109
393
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.5
17.8
53
101
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.9
17.6
111
411
UDM02
NOMESCO Finland
Sinoscopy
6.3
17.6
47
78
SPAT1255
SPAT
Intravenous administration of medicine
3.8
17.6
78
222
A01AB04
ATC
amphotericin B; local oral
4.7
17.6
61
138
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
4.9
17.5
58
125
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
17.4
143
620
WX892
NOMESCO Finland
Monitored bed care
3.2
17.3
93
309
J01.1
ICD-10 Finland
Acute frontal sinusitis
7.4
17.2
41
58
X59
ICD-10 Finland
Exposure to unspecified factor
2.2
17.1
192
977
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
10.3
17.0
33
33
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
26.2
17.0
23
9
J01CA04
ATC
amoxicillin; systemic
2.2
16.9
736
6234
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
14.4
16.9
28
20
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
16.9
182
905
D80.4
ICD-10 Finland
Selective deficiency of immunoglobulin M [IgM]
+∞
16.7
16
*
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
16.7
16
*
L04AA13
ATC
leflunomide; oral
5.9
16.7
47
84
A28
ICPC
Limited function/disability NOS
2.7
16.6
119
477
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
6.7
16.6
42
65
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
16.6
172
840
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
16.6
125
517
H65.2
ICD-10 Finland
Chronic serous otitis media
7.7
16.6
38
51
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
28.2
16.6
22
8
L01BB05
ATC
fludarabine; systemic
173.1
16.5
17
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
16.5
88
291
R06AX27
ATC
desloratadine; oral
1.9
16.2
287
1759
Z50.1
ICD-10 Finland
Other physical therapy
3.8
16.1
70
196
B99
ICD-10 Finland
Other and unspecified infectious diseases
7.9
16.0
36
47
ZYC01
NOMESCO Finland
Remote contact by phone
3.7
15.9
72
209
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
8.2
15.9
35
44
L04AA01
ATC
[U] ciclosporin; systemic
7.5
15.9
37
51
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
61.2
15.8
18
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.8
15.8
108
421
B28
ICPC
Limited function/disability (B)
34.1
15.8
20
6
D84.1
ICD-10 Finland
Defects in the complement system
+∞
15.7
15
*
N06AA09
ATC
amitriptyline; systemic
2.8
15.6
105
402
SPAT1325
SPAT
Vaccination
1.9
15.6
296
1853
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.0
15.6
226
1279
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
15.5
387
2657
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
15.5
218
1216
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
15.1
15.4
25
17
B01AB05
ATC
enoxaparin; parenteral
2.0
15.3
258
1542
J33.8
ICD-10 Finland
Other polyp of sinus
7.3
15.2
36
51
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
15.2
123
529
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
15.2
68
196
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.5
15.2
45
86
J32.8
ICD-10 Finland
Other chronic sinusitis
23.9
15.2
21
9
R03BC03
ATC
nedocromil; inhalant
3.2
15.1
84
283
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.5
15.0
122
526
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
12.7
14.9
26
21
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
10.7
14.8
28
27
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
14.8
177
921
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
25.5
14.7
20
8
R74
ICPC
Upper respiratory infection acute
1.9
14.7
290
1832
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.1
14.7
58
150
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
14.6
14
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
14.5
215
1220
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
6.4
14.5
38
62
L04AD01
ATC
ciclosporin; systemic
5.9
14.5
40
70
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.1
14.4
57
147
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
17.3
14.3
22
13
A07AA09
ATC
vancomycin; oral
10.7
14.3
27
26
H66.9
ICD-10 Finland
Otitis media, unspecified
3.0
14.3
86
308
R01AD01
ATC
beclometasone; nasal
2.2
14.3
157
784
J01FA01
ATC
erythromycin; systemic
2.2
14.3
155
770
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
22.7
14.3
20
9
H65.3
ICD-10 Finland
Chronic mucoid otitis media
4.7
14.2
48
106
ZXD20
NOMESCO Finland
Day surgery
2.3
14.1
138
652
WX872
NOMESCO Finland
Intensive care
3.9
14.0
58
156
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.9
13.9
88
324
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
30.6
13.9
18
6
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.1
13.9
169
883
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.9
13.9
267
1666
A06AD11
ATC
lactulose; oral
2.5
13.9
115
500
DPA20
NOMESCO Finland
Trephine of frontal sinus
54.2
13.8
16
*
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
20.4
13.8
20
10
M05BB03
ATC
alendronic acid and colecalciferol; oral
6.3
13.8
36
59
TQW99
NOMESCO Finland
Other minor procedure on skin
3.9
13.7
57
154
A04AA02
ATC
granisetron; systemic, transdermal
3.4
13.7
67
207
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.0
13.7
55
144
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
13.7
78
269
J01DC02
ATC
cefuroxime; systemic
3.1
13.7
75
253
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.9
13.7
253
1555
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
13.7
116
510
Z71.8
ICD-10 Finland
Other specified counselling
1.9
13.7
228
1349
C82.1
ICD-10 Finland
Follicular lymphoma grade II
15.0
13.6
22
15
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
13.6
13
*
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
13.6
13
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
13.6
13
*
132
Kela drug reimbursment
Sarcoidosis
+∞
13.6
13
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.9
13.6
251
1544
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.9
13.6
86
318
N05CD07
ATC
temazepam; oral
2.6
13.5
106
446
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.0
13.3
180
984
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
13.3
129
608
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.0
13.2
32
47
S97
ICPC
Chronic ulcer skin
3.9
13.2
55
149
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.7
13.2
58
165
UJF92
NOMESCO Finland
Capsular endoscopy
5.4
13.1
39
75
TK800
NOMESCO Finland
Hemodialysis
6.4
13.1
34
55
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
13.1
91
355
R53
ICD-10 Finland
Malaise and fatigue
2.0
13.0
189
1060
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.0
13.0
79
284
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
7.5
13.0
30
41
WW300
NOMESCO Finland
Transfer of autologic stem cells
17.0
13.0
20
12
ZX110
NOMESCO Finland
Intracutaneous
28.8
13.0
17
6
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
13.0
83
309
J33.0
ICD-10 Finland
Polyp of nasal cavity
5.5
13.0
38
72
C07AB07
ATC
bisoprolol; oral
1.7
13.0
342
2352
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.3
12.9
133
641
L28
ICPC
Limited function/disability (L)
2.3
12.9
133
642
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.5
12.9
104
445
3XA02
NOMESCO Finland
NA
50.8
12.9
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.1
12.8
50
128
R1250
NOMESCO Finland
Evaluation of functional capability
4.7
12.8
43
95
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
10.7
12.8
24
23
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
10.7
12.8
24
23
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.9
12.8
80
295
E86
ICD-10 Finland
Volume depletion
6.9
12.8
31
46
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.5
12.7
45
105
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.9
12.7
78
284
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.7
12.7
56
160
R4120
NOMESCO Finland
Occupational therapy
3.0
12.7
74
261
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
12.5
12.7
22
18
C10AC01
ATC
colestyramine; oral
4.5
12.6
44
101
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
32.5
12.6
16
5
A03
ICPC
Fever
2.0
12.5
171
935
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
20.4
12.5
18
9
R96
ICPC
Asthma
2.6
12.4
91
369
3AC01
NOMESCO Finland
NA
8.2
12.4
27
34
DPA30
NOMESCO Finland
Sphenotomy
14.6
12.3
20
14
RD210
NOMESCO Finland
NA
4.8
12.3
40
86
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
3.9
12.2
50
134
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.9
12.2
50
134
M35.7
ICD-10 Finland
Hypermobility syndrome
6.2
12.2
32
53
B03XA02
ATC
darbepoetin alfa; parenteral
7.9
12.2
27
35
J96.0
ICD-10 Finland
Acute respiratory failure
12.6
12.2
21
17
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
12.1
384
2774
M05BA07
ATC
risedronic acid; oral
5.2
12.1
37
74
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
12.1
52
146
H02AB02
ATC
dexamethasone; systemic
2.5
12.1
95
401
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
6.1
12.0
32
54
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
10.2
12.0
23
23
I50.9
ICD-10 Finland
Heart failure, unspecified
2.8
12.0
81
310
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
12.0
88
355
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
12.0
101
443
A07EA06
ATC
budesonide; oral, local oral
3.9
11.9
49
132
390
Kela drug reimbursment
Ibrutinib
47.3
11.9
14
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
47.3
11.9
14
*
R06AX22
ATC
ebastine; oral
2.0
11.9
175
985
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
11.9
11.9
21
18
C03DA01
ATC
spironolactone; oral
2.6
11.8
88
360
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.8
11.8
39
85
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
9.8
11.8
23
24
N19
ICD-10 Finland
Unspecified kidney failure
6.1
11.7
31
52
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.3
11.7
58
182
H26.3
ICD-10 Finland
Drug-induced cataract
16.7
11.7
18
11
WX722
NOMESCO Finland
PEEP
3.5
11.7
54
161
A02BA02
ATC
ranitidine; systemic
2.0
11.6
162
888
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
19.2
11.6
17
9
J01
ICD-10 Finland
Acute sinusitis
3.1
11.6
65
221
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
11.3
11.6
21
19
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
11.5
314
2163
4222
FHL
Endonasal etmoidectomy
13.8
11.5
19
14
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.0
11.4
66
231
318
Kela drug reimbursment
Teriparatide
15.3
11.3
18
12
DMB10
NOMESCO Finland
Radical maxillary antrotomy
15.3
11.3
18
12
Z2445
NOMESCO Finland
Psychologist
3.0
11.3
66
233
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
17.3
11.2
17
10
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.7
11.2
80
318
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
12.9
11.2
19
15
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
25.4
11.2
15
6
L01AA01
ATC
cyclophosphamide; systemic
20.3
11.2
16
8
N03AX11
ATC
topiramate; oral
4.1
11.1
43
110
B34.9
ICD-10 Finland
Viral infection, unspecified
4.1
11.1
43
110
R06AX13
ATC
loratadine; oral
2.0
11.1
158
873
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
5.0
11.1
35
73
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
9.4
11.0
22
24
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
11.0
47
131
R01BA01
ATC
phenylpropanolamine; oral
3.0
11.0
63
219
XCK10
NOMESCO Finland
Photography of fundus of eye
2.5
11.0
91
394
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.1
11.0
60
203
DHB50
NOMESCO Finland
Turbinoplasty
4.6
11.0
37
83
R05
ICPC
Cough
1.9
10.9
196
1180
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.3
10.9
106
497
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.7
10.9
36
79
J01EA01
ATC
trimethoprim; systemic
1.8
10.9
211
1304
EB1WA
NOMESCO Finland
NA
12.1
10.9
19
16
H05AA02
ATC
teriparatide; parenteral
15.7
10.9
17
11
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.5
10.8
50
149
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
10.8
103
478
R06AX26
ATC
fexofenadine; oral
2.7
10.8
74
287
E87.6
ICD-10 Finland
Hypokalaemia
4.4
10.8
38
89
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
9.7
10.8
21
22
R02
ICPC
Shortness of breath/dyspnoea
2.3
10.8
105
493
R11
ICD-10 Finland
Nausea and vomiting
2.5
10.7
84
353
WX882
NOMESCO Finland
High dependency care
3.8
10.7
45
124
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
7.7
10.7
24
32
XG466
NOMESCO Finland
Sleep oxymetry
4.0
10.7
42
109
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.8
10.7
35
76
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.0
10.7
62
218
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.4
10.7
27
43
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.6
10.6
80
329
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.9
10.5
42
111
J05AB09
ATC
famciclovir; oral
14.4
10.5
17
12
UJD02
NOMESCO Finland
Gastroscopy
3.3
10.5
52
164
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.0
10.5
28
48
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
10.5
89
392
2790A
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[AGAMMAGLOBULINAEMIA (BRUTON)]
+∞
10.4
10
*
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
10.4
10
*
D80.5
ICD-10 Finland
Immunodeficiency with increased immunoglobulin M [IgM]
+∞
10.4
10
*
UKC02
NOMESCO Finland
Cystoscopy
2.2
10.4
114
563
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
6.5
10.4
26
41
C90.0
ICD-10 Finland
Multiple myeloma
12.2
10.4
18
15
C83.00
ICD-10 Finland
Lymphocytic lymphoma
32.9
10.3
13
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
6.2
10.3
27
45
A07EC01
ATC
sulfasalazine; oral, rectal
2.5
10.3
84
359
N30.0
ICD-10 Finland
Acute cystitis
2.1
10.3
124
641
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
7.6
10.2
23
31
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.8
10.2
42
114
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
10.2
58
201
H92.0
ICD-10 Finland
Otalgia
2.8
10.1
64
238
C08DA01
ATC
verapamil; systemic
3.7
10.1
44
125
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
5.1
10.1
31
63
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.5
10.1
35
81
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
11.5
10.1
18
16
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.7
10.0
43
121
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
10.0
91
414
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.6
10.0
34
77
K90.0
ICD-10 Finland
Coeliac disease
3.8
10.0
41
111
1512
Kela drug reimbursment
Ibrutinib
40.5
10.0
12
*
JN6AD
NOMESCO Finland
CT of torso and neck
6.8
9.9
24
36
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
6.8
9.9
24
36
AA1AD
NOMESCO Finland
CT of head and brain
1.8
9.9
178
1065
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
9.9
206
1294
RS221
NOMESCO Finland
NA
5.1
9.9
30
60
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.3
9.9
48
149
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.6
9.9
73
297
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.0
9.9
39
102
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
16.9
9.9
15
9
B01AB04
ATC
dalteparin; parenteral
3.4
9.9
47
144
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.1
9.9
26
44
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
7.1
9.8
23
33
G44.2
ICD-10 Finland
Tension-type headache
2.0
9.8
130
696
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
9.8
196
1219
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
9.7
9.8
19
20
XCK00
NOMESCO Finland
Perimetry
2.7
9.8
65
249
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.9
9.8
58
208
ZX100
NOMESCO Finland
Oral
6.6
9.8
24
37
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
9.8
69
275
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.7
9.7
41
114
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.5
9.7
33
75
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.3
9.7
47
146
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
13.6
9.7
16
12
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.0
9.7
30
62
UDC00
NOMESCO Finland
Ear microscopy
2.6
9.6
71
290
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
8.5
9.6
20
24
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
11.5
9.6
17
15
R75
ICPC
Sinusitis acute/chronic
3.1
9.6
52
176
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
9.6
49
159
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.2
9.6
49
159
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.4
9.6
85
382
R49.01
ICD-10 Finland
Functional dysphonia
3.6
9.5
42
122
M79.6
ICD-10 Finland
Pain in limb
1.6
9.5
300
2125
M31.1
ICD-10 Finland
Thrombotic microangiopathy
101.1
9.4
10
*
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
4.1
9.4
35
87
YNB10
NOMESCO Finland
Collection of stem cells for transplant
17.8
9.4
14
8
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
17.8
9.4
14
8
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
30.4
9.4
12
*
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
9.4
9
*
D81.1
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
+∞
9.4
9
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
9.4
9
*
5BA08
NOMESCO Finland
NA
12.5
9.4
16
13
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
9.4
91
426
X57
ICD-10 Finland
Unspecified privation
4.6
9.3
31
69
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.0
9.3
121
644
B03BA03
ATC
hydroxocobalamin; parenteral
3.1
9.3
50
168
H01
ICPC
Ear pain/earache
2.1
9.3
107
543
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
9.6
9.3
18
19
J05AH02
ATC
oseltamivir; oral
9.6
9.3
18
19
N06AX11
ATC
mirtazapine; oral
1.7
9.3
262
1798
N06AX16
ATC
venlafaxine; oral
2.0
9.3
132
730
R52.9
ICD-10 Finland
Pain, unspecified
2.4
9.2
78
343
R4190
NOMESCO Finland
Nutritional therapy
3.2
9.2
47
153
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
4.1
9.1
34
85
R42
ICD-10 Finland
Dizziness and giddiness
1.8
9.1
157
929
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
9.1
74
318
TKC20
NOMESCO Finland
Catheterisation of bladder
2.8
9.1
58
218
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.1
9.1
21
30
M05BX04
ATC
denosumab; parenteral
3.1
9.1
48
160
TK810
NOMESCO Finland
Hemofiltration
15.8
9.0
14
9
G93.3
ICD-10 Finland
Postviral fatigue syndrome
15.8
9.0
14
9
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
10.2
9.0
17
17
4AA24
NOMESCO Finland
NA
37.1
9.0
11
*
1CX01
NOMESCO Finland
NA
37.1
9.0
11
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.7
9.0
60
229
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.7
9.0
61
238
A11CC03
ATC
alfacalcidol; systemic
4.7
9.0
29
63
PJA10
NOMESCO Finland
Exploration of lymph nodes
7.6
9.0
20
27
C83.1
ICD-10 Finland
Mantle cell lymphoma
18.8
8.9
13
7
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
18.8
8.9
13
7
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.3
8.9
44
139
XG405
NOMESCO Finland
Education on PEF monitoring
5.8
8.9
24
42
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.8
8.9
24
42
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
24.3
8.9
12
5
L88
ICPC
Rheumatoid/seropositive arthritis
3.2
8.9
45
145
R05CB02
ATC
bromhexine; systemic
8.1
8.9
19
24
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.1
8.9
99
493
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
6.9
8.9
21
31
4224
FHL
Endonasal anthrostomy
6.9
8.9
21
31
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.6
8.9
39
113
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.7
8.8
29
64
N03AE01
ATC
clonazepam; systemic
2.6
8.8
61
241
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.3
8.8
43
135
D07AC01
ATC
betamethasone; topical
1.6
8.8
276
1945
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.8
8.8
16
15
R60.0
ICD-10 Finland
Localized oedema
2.2
8.8
88
420
M01CB01
ATC
sodium aurothiomalate; parenteral
5.4
8.8
25
47
J01DC04
ATC
cefaclor; oral
5.4
8.8
25
47
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.3
8.8
78
352
Z94.0
ICD-10 Finland
Kidney transplant status
7.3
8.8
20
28
D07AA02
ATC
hydrocortisone; topical
1.9
8.8
137
783
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
2.7
8.7
59
230
RK110
NOMESCO Finland
NA
6.7
8.7
21
32
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
8.7
62
248
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
8.7
290
2076
M13.9
ICD-10 Finland
Arthritis, unspecified
2.4
8.7
72
314
R01AD11
ATC
triamcinolone; nasal
2.2
8.7
89
429
I50.0
ICD-10 Finland
Congestive heart failure
3.4
8.7
41
126
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.7
8.7
28
61
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
8.7
355
2670
S01GX05
ATC
lodoxamide; ophthalmic
6.2
8.7
22
36
K07.60
ICD-10 Finland
Snapping jaw
2.7
8.6
56
213
A12AA04
ATC
calcium carbonate; oral
5.9
8.6
23
40
X58
ICD-10 Finland
Exposure to other specified factors
1.9
8.6
125
695
M25.5
ICD-10 Finland
Pain in joint
1.6
8.6
249
1718
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.7
8.6
58
225
N05BA06
ATC
lorazepam; systemic, sublingual
3.1
8.6
46
155
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.0
8.6
20
29
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.5
8.6
65
270
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
9.1
8.6
17
19
J15.8
ICD-10 Finland
Other bacterial pneumonia
10.2
8.5
16
16
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.1
8.5
45
150
W19
ICD-10 Finland
Unspecified fall
2.3
8.5
81
377
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
3.4
8.5
39
117
N03AX09
ATC
lamotrigine; oral
2.7
8.5
55
209
J06.80
ICD-10 Finland
Continuously repeating infections of a child
20.2
8.5
12
6
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
20.2
8.5
12
6
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
5.7
8.5
23
41
XF404
NOMESCO Finland
Ambulatory ECG
2.3
8.5
78
357
K11.2
ICD-10 Finland
Sialoadenitis
3.6
8.4
36
102
H10.4
ICD-10 Finland
Chronic conjunctivitis
6.8
8.4
20
30
49300
ICD-8 Finland
Asthma, bronchiale
4.4
8.4
29
68
R13
ICD-10 Finland
Dysphagia
2.7
8.4
57
223
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
4.2
8.3
30
73
WZA10
NOMESCO Finland
Long statement of health and health related matters
5.6
8.3
23
42
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
5.6
8.3
23
42
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.8
8.3
34
93
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
9.6
8.3
16
17
L50.9
ICD-10 Finland
Urticaria, unspecified
3.2
8.2
42
137
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.2
8.2
81
382
4239
FHL
Other measure in this category
14.6
8.2
13
9
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.5
8.2
23
43
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.0
8.2
99
514
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
8.1
98
505
M79.7
ICD-10 Finland
Fibromyalgia
3.3
8.1
39
122
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
33.7
8.1
10
*
Z94.2
ICD-10 Finland
Lung transplant status
33.7
8.1
10
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
17.4
8.1
12
7
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
9.0
8.1
16
18
N17.8
ICD-10 Finland
Other acute renal failure
9.0
8.1
16
18
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
8.0
195
1275
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
10.1
8.0
15
15
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
8.0
80
380
S18
ICPC
Laceration/cut
1.5
8.0
319
2372
WX110
NOMESCO Finland
Local anesthesy
1.5
8.0
590
5032
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.1
8.0
93
472
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
8.0
122
689
R01AC01
ATC
cromoglicic acid; nasal
2.8
7.9
48
176
DHB20
NOMESCO Finland
Polypectomy of internal nose
6.7
7.9
19
29
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.0
7.9
106
570
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
7.9
63
268
V03AE01
ATC
polystyrene sulfonate; oral
8.6
7.8
16
19
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.6
7.8
16
19
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
10.9
7.8
14
13
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
7.8
180
1163
J01MA01
ATC
ofloxacin; systemic
2.3
7.7
69
313
E000001
ATC
NA
1.7
7.7
182
1179
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.5
7.7
60
253
L04AB04
ATC
adalimumab; parenteral
4.2
7.7
28
69
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.7
7.7
32
89
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
45.4
7.7
9
*
Z31.5
ICD-10 Finland
Genetic counselling
2.5
7.7
59
245
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
7.5
7.7
17
23
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.4
7.7
26
60
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.8
7.7
24
51
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
7.7
60
255
N05BA04
ATC
oxazepam; oral
1.7
7.6
194
1284
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.7
7.6
31
85
B03XA01
ATC
erythropoietin; parenteral
8.1
7.6
16
20
E000002
ATC
NA
1.9
7.6
110
610
R50.0
ICD-10 Finland
Fever with chills
18.5
7.6
11
6
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
12.0
7.6
13
11
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
12.0
7.6
13
11
G03.9
ICD-10 Finland
Meningitis, unspecified
25.2
7.6
10
*
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
4.4
7.6
26
61
M01AH02
ATC
rofecoxib; oral
2.0
7.6
100
536
A01
ICPC
Pain general/multiple sites
2.3
7.5
67
303
C08CA01
ATC
amlodipine; oral
1.6
7.5
225
1557
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.9
7.5
43
152
M03BX01
ATC
baclofen; systemic
4.3
7.5
26
62
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.3
7.4
35
108
B02.9
ICD-10 Finland
Zoster without complication
2.6
7.4
51
200
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
6.5
7.4
18
28
NF1AA
NOMESCO Finland
Hip X-ray examination
2.3
7.4
67
306
GD1BG
NOMESCO Finland
MRI of lungs and pleura with high intensity magnet
80.7
7.4
8
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
80.7
7.4
8
*
ZX131
NOMESCO Finland
Intrathecal
80.7
7.4
8
*
M35.2
ICD-10 Finland
Behçet disease
80.7
7.4
8
*
212
Kela drug reimbursment
Gout
5.4
7.4
21
40
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
5.4
7.4
21
40
SBA00
NOMESCO Finland
Microbiological examinations
3.8
7.4
30
82
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.9
7.4
29
77
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.0
7.4
19
32
JMA10
NOMESCO Finland
Transabdominal total splenectomy
13.5
7.4
12
9
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
4.8
7.4
23
49
Z49.0
ICD-10 Finland
Preparatory care for dialysis
8.5
7.3
15
18
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
7.3
212
1454
602
Kela drug reimbursment
Children's severe malnutrition
6.9
7.3
17
25
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.0
7.3
22
45
D81.9
ICD-10 Finland
Combined immunodeficiency, unspecified
+∞
7.3
7
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
7.3
7
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
7.3
7
*
D89.9
ICD-10 Finland
Disorder involving the immune mechanism, unspecified
+∞
7.3
7
*
D81.8
ICD-10 Finland
Other combined immunodeficiencies
+∞
7.3
7
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.1
7.3
38
127
N06AX17
ATC
milnacipran; oral
5.9
7.2
19
33
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.6
7.2
31
89
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
15.9
7.2
11
7
G47.3
ICD-10 Finland
Sleep apnoea
1.7
7.2
164
1050
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.4
7.2
60
263
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.8
7.2
44
163
H65.0
ICD-10 Finland
Acute serous otitis media
4.5
7.2
24
55
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.9
7.2
22
46
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
7.2
87
450
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.3
7.2
62
277
ELA30
NOMESCO Finland
Biopsy of salivary gland
20.2
7.1
10
5
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
6.6
7.1
17
26
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.0
7.1
15
19
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
7.1
87
454
H20.1
ICD-10 Finland
Chronic iridocyclitis
6.1
7.1
18
30
R04.0
ICD-10 Finland
Epistaxis
2.4
7.1
56
239
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
5.7
7.1
19
34
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
5.7
7.1
19
34
WX402
NOMESCO Finland
General anaesthesia
1.7
7.1
141
868
R49.08
ICD-10 Finland
Other specified dysphonia
3.5
7.1
31
91
L03AA14
ATC
lipegfilgrastim; parenteral
4.0
7.0
26
66
G81.9
ICD-10 Finland
Hemiplegia, unspecified
7.1
7.0
16
23
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.5
7.0
55
233
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.4
7.0
58
253
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.5
7.0
31
92
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.6
7.0
48
188
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.3
7.0
33
103
D07AB08
ATC
desonide; topical
1.9
7.0
94
510
S01BC05
ATC
ketorolac; ophthalmic
3.5
7.0
30
87
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.1
6.9
36
120
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.5
6.9
19
35
RS220
NOMESCO Finland
NA
4.7
6.9
22
48
GBB00
NOMESCO Finland
Tracheostomy
7.6
6.9
15
20
A07EC02
ATC
mesalazine; oral, rectal
2.4
6.9
55
236
L82
ICD-10 Finland
Seborrhoeic keratosis
1.8
6.9
110
632
R60.9
ICD-10 Finland
Oedema, unspecified
2.8
6.9
41
149
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
13.9
6.9
11
8
B99
ICPC
Blood/lymph/spleen disease other
13.9
6.9
11
8
N06AB04
ATC
citalopram; systemic
1.6
6.9
177
1174
R06.2
ICD-10 Finland
Wheezing
2.6
6.9
46
180
H25.1
ICD-10 Finland
Senile nuclear cataract
1.8
6.9
131
795
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
6.8
231
1641
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.2
6.8
24
58
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
8.3
6.8
14
17
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
8.3
6.8
14
17
TEA00
NOMESCO Finland
Biopsy of lip
8.3
6.8
14
17
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
3.6
6.8
29
83
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.5
6.8
51
211
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.9
6.8
40
144
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.3
6.8
62
283
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
11.0
6.8
12
11
RK220
NOMESCO Finland
NA
11.0
6.8
12
11
J30.0
ICD-10 Finland
Vasomotor rhinitis
3.4
6.8
31
94
J01MA06
ATC
norfloxacin; oral
1.9
6.8
105
595
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.3
6.8
59
263
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.0
6.8
37
128
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
40.4
6.8
8
*
D73.1
ICD-10 Finland
Hypersplenism
40.4
6.8
8
*
L57.0
ICD-10 Finland
Actinic keratosis
2.3
6.7
59
265
R4130
NOMESCO Finland
Speech therapy
4.2
6.7
24
59
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.3
6.7
31
95
R04
ICPC
Breathing problem other
3.2
6.7
33
106
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.2
6.7
33
106
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
7.2
6.7
15
21
A03FA02
ATC
cisapride; oral, rectal
2.2
6.7
64
300
JN4CD
NOMESCO Finland
Very extensive body CT
3.1
6.7
34
112
B01AA03
ATC
warfarin; systemic
1.8
6.7
108
623
2AX04
NOMESCO Finland
NA
22.7
6.7
9
*
L01AA02
ATC
chlorambucil; oral
22.7
6.7
9
*
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
2.5
6.7
48
196
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
6.5
6.7
16
25
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
7.9
6.6
14
18
R51.81
ICD-10 Finland
Facial pain NOS
3.7
6.6
27
75
R05CB01
ATC
acetylcysteine; inhalant, oral
4.7
6.6
21
46
M48.0
ICD-10 Finland
Spinal stenosis
2.0
6.6
81
422
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.9
6.6
91
497
E66.9
ICD-10 Finland
Obesity, unspecified
3.0
6.6
35
119
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
12.4
6.6
11
9
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
12.4
6.6
11
9
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
12.4
6.6
11
9
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
8.8
6.6
13
15
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.8
6.6
20
42
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.5
6.5
28
81
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
10.1
6.5
12
12
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
6.9
6.5
15
22
B00.10
ICD-10 Finland
Herpes simplex facialis
6.9
6.5
15
22
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.0
6.5
81
426
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.2
6.5
63
298
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.9
6.5
90
491
DFF00
NOMESCO Finland
Pure tone audiometry
2.1
6.5
74
375
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.9
6.5
38
137
J02AC02
ATC
itraconazole; systemic
1.7
6.5
148
948
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
6.5
92
508
C07AB02
ATC
metoprolol; systemic
1.7
6.5
126
770
XKD00
NOMESCO Finland
Uroflowmetry
1.9
6.5
92
509
J34.2
ICD-10 Finland
Deviated nasal septum
2.5
6.4
46
187
WX720
NOMESCO Finland
Own respiration
2.9
6.4
37
131
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.2
6.4
60
279
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
6.4
192
1322
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
70.3
6.4
7
*
B05XA03
ATC
sodium chloride; parenteral
70.3
6.4
7
*
J01XB01
ATC
colistin; inhalant, parenteral
70.3
6.4
7
*
Z29.1
ICD-10 Finland
Prophylactic immunotherapy
70.3
6.4
7
*
27510
ICD-8 Finland
Plasma protein abnormalities, Hypogammaglobulinaemia
70.3
6.4
7
*
K59.1
ICD-10 Finland
Functional diarrhoea
2.5
6.4
48
198
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.2
6.4
60
280
WX730
NOMESCO Finland
Conventional respirator
4.5
6.4
21
48
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
4.5
6.4
21
48
R09
ICPC
Sinus symptom/complaint
2.0
6.4
75
384
B81
ICPC
Anaemia vit B12/folate deficiency
3.1
6.4
32
105
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
6.3
54
240
RS224
NOMESCO Finland
NA
8.2
6.3
13
16
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
6.3
110
647
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
5.2
6.3
18
35
R05FB02
ATC
cough suppressants and expectorants
1.5
6.3
277
2081
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.6
6.3
26
73
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.0
6.3
34
117
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.6
6.3
20
44
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
11.1
6.3
11
10
RJ420
NOMESCO Finland
NA
11.1
6.3
11
10
M81.8
ICD-10 Finland
Other osteoporosis
9.3
6.3
12
13
G72.9
ICD-10 Finland
Myopathy, unspecified
9.3
6.3
12
13
M01AG02
ATC
tolfenamic acid; oral, rectal
1.7
6.3
134
842
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.7
6.3
137
866
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.6
6.3
42
165
J02AC03
ATC
voriconazole; systemic
18.2
6.3
9
5
WW409
NOMESCO Finland
Other aferesis
18.2
6.3
9
5
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.6
6.3
44
176
K12.00
ICD-10 Finland
Recurrent oral aphthae
4.8
6.2
19
40
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.8
6.2
19
40
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
26.9
6.2
8
*
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
26.9
6.2
8
*
GX1K5
NOMESCO Finland
Diffusion capacity
26.9
6.2
8
*
S29
ICPC
Skin symptom/complaint other
1.7
6.2
129
806
A99
ICPC
Disease/condition unspecnature/site
2.1
6.2
66
326
A05AA02
ATC
ursodeoxycholic acid; oral
3.8
6.2
24
64
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.7
6.2
40
152
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
6.3
6.2
15
24
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
5.4
6.2
17
32
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
5.8
6.2
16
28
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.7
6.2
38
143
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
7.7
6.1
13
17
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
3.8
6.1
24
65
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
12.6
6.1
10
8
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
12.6
6.1
10
8
M35.1
ICD-10 Finland
Other overlap syndromes
12.6
6.1
10
8
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
12.6
6.1
10
8
5AB14
NOMESCO Finland
NA
12.6
6.1
10
8
L20.0
ICD-10 Finland
Besnier prurigo
2.0
6.1
71
364
ZXC20
NOMESCO Finland
Use of chemical agents
4.9
6.1
18
37
J32
ICD-10 Finland
Chronic sinusitis
8.7
6.1
12
14
DHA10
NOMESCO Finland
Biopsy of cavity of nose
8.7
6.1
12
14
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.6
6.0
41
163
R23.3
ICD-10 Finland
Spontaneous ecchymoses
4.2
6.0
21
51
N06AA10
ATC
nortriptyline; systemic
3.6
6.0
25
71
SXC03
NOMESCO Finland
Other oral or dental procedure
5.2
6.0
17
33
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
5.2
6.0
17
33
K50.8
ICD-10 Finland
Other Crohn disease
4.0
6.0
22
56
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.0
6.0
22
56
R03BC01
ATC
cromoglicic acid; inhalant
3.8
6.0
23
61
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
6.0
81
440
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005719) IgG [Mass/volume] in Serum or Plasma
672
600
35.08
307.65
12.2
2.5
g/l
8.6
10.4
16.42
662
553
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
284
46
87.29
307.65
2.5
2.0
%
12.5
9.2
1.06
179
23
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
246
48
68.59
307.65
2.6
1.9
e6/l
554.8
784.9
0.54
207
37
(3011412) CD3 cells [#/volume] in Blood
331
65
77.24
307.65
2.7
2.0
e9/l
1.3
1.2
0.25
239
33
(3028192) IgG subclass 2 [Mass/volume] in Serum
276
71
54.18
307.65
2.1
1.3
g/l
1.9
2.6
3.17
229
51
(3024980) IgG subclass 4 [Mass/volume] in Serum
287
121
33.42
307.65
2.1
1.8
g/l
0.3
0.8
3.38
232
95
(3027135) IgG subclass 1 [Mass/volume] in Serum
275
71
53.90
307.65
2.1
1.3
g/l
4.9
7.5
3.47
230
52
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
201
55
45.97
307.65
2.5
1.7
e6/l
749.6
739.6
0.03
59
22
(4062490)
281
73
54.03
307.65
2.3
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
275
71
53.90
307.65
2.1
1.3
g/l
0.3
0.4
2.13
229
51
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
242
45
71.59
307.65
2.7
1.9
e9/l
0.2
0.2
0.29
207
36
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
294
45
93.78
307.65
2.6
2.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
263
59
61.04
307.65
2.5
1.9
%
36.9
44.0
—
21
6
(3028026) IgM [Mass/volume] in Serum or Plasma
562
482
26.75
307.65
4.5
1.7
g/l
1.0
1.3
2.40
509
449
(3000060) B lymphocytes [#/volume] in Blood
162
24
81.02
302.30
2.4
1.8
e6/l
546.7
307.8
—
117
9
(3005322) IgE [Units/volume] in Serum or Plasma
375
558
10.39
260.89
1.8
1.2
u/ml
74.4
193.1
1.98
300
516
(3007164) IgA [Mass/volume] in Serum or Plasma
632
1772
8.53
243.02
4.4
1.5
g/l
1.4
2.3
29.52
470
1084
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
217
174
15.83
230.12
3.1
1.2
mg/l
11.4
10.6
0.61
210
156
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
112
21
60.25
199.30
1.2
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
111
21
59.65
197.15
1.2
1.1
%
96.8
93.0
0.21
111
21
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
176
137
15.51
188.63
6.1
6.7
iu/ml
942.8
397.3
0.43
32
20
(3023419) Bacteria identified in Sputum by Culture
149
90
19.42
182.34
4.1
3.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
103
23
50.05
176.50
2.4
1.9
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
218
263
10.43
174.38
2.1
1.7
g/l
0.2
0.2
1.05
202
249
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
222
275
10.20
174.03
2.1
1.6
g/l
1.2
1.2
0.81
210
259
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
94
20
52.00
162.57
2.5
2.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
836
3953
9.69
162.41
20.2
5.8
e9/l
0.6
0.6
0.40
810
3423
(3006315) Basophils [#/volume] in Blood
836
3966
9.64
161.39
20.3
5.8
e9/l
0.0
0.0
1.13
809
3436
(42870588) Differential panel, method unspecified - Blood
671
2624
6.19
161.10
18.8
5.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
149
116
15.02
158.94
4.1
4.7
u/ml
8831.8
2970.8
—
12
9
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
174
175
11.93
158.03
2.5
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
173
177
11.71
155.20
2.4
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
839
4078
9.45
154.93
20.5
5.8
e9/l
2.0
1.9
0.12
821
3601
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
105
42
27.95
152.08
2.7
2.4
%
40.0
43.9
—
37
10
(3013115) Eosinophils [#/volume] in Blood
839
4118
9.29
151.95
21.3
6.2
e9/l
0.2
0.2
0.80
821
3624
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
314
689
6.29
144.59
4.1
2.6
g/l
0.2
0.2
2.73
303
652
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
266
501
6.96
143.10
3.2
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
166
181
10.88
142.00
3.1
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
393
1075
5.50
141.02
3.4
1.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
765
3611
6.53
139.46
21.1
6.0
%
0.7
0.7
0.29
753
3378
(3019069) Monocytes/100 leukocytes in Blood
774
3742
6.54
135.51
21.8
6.2
%
8.8
8.4
2.53
763
3519
(3006504) Eosinophils/100 leukocytes in Blood
771
3721
6.47
135.09
21.3
5.9
%
2.7
2.9
1.65
759
3482
(3018010) Neutrophils/100 leukocytes in Blood
775
3810
6.39
131.17
20.0
5.7
%
57.5
56.4
1.50
761
3582
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
137
127
12.42
130.68
2.4
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
779
3857
6.43
130.38
21.4
6.0
%
28.5
29.0
0.58
767
3618
(3013650) Neutrophils [#/volume] in Blood by Automated count
848
4602
8.28
125.09
27.3
8.8
e9/l
4.0
4.0
0.30
824
4026
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
305
750
5.50
121.87
2.8
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
495
1800
4.62
121.04
9.6
4.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
130
129
11.50
118.22
2.1
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
294
757
5.16
110.25
3.0
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
107
88
13.56
109.63
3.7
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
98
74
14.64
105.51
3.9
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
344
1038
4.61
105.28
3.2
2.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
237
535
5.56
103.01
4.1
2.8
g/l
62.8
67.2
10.01
228
492
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
105
97
12.03
99.82
2.0
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
137
182
8.62
99.58
1.8
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
91
69
14.47
97.62
3.1
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
299
856
4.62
97.07
2.6
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
91
70
14.26
96.80
3.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
83
55
16.43
95.83
1.8
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
487
2024
3.86
92.98
17.4
6.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
102
102
11.07
91.79
2.2
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
168
305
6.47
91.55
3.0
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
304
918
4.38
91.44
2.4
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
61
22
29.54
90.88
3.1
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
201
450
5.39
87.30
4.1
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
243
638
4.76
87.23
9.2
4.5
%
0.9
1.0
0.26
108
187
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
302
942
4.22
86.40
3.8
2.4
%
21.5
23.7
1.60
278
820
(3002179) Metamyelocytes/100 leukocytes in Blood
231
587
4.87
86.28
8.4
4.3
%
0.6
0.6
0.00
87
135
(3004789) Transferrin [Mass/volume] in Serum or Plasma
315
1017
4.12
85.85
3.8
2.3
g/l
2.4
2.4
0.40
306
948
(3003458) Phosphate [Moles/volume] in Serum or Plasma
302
949
4.19
85.41
13.0
5.8
mmol/l
1.1
1.1
0.11
296
884
(3028433) Virus identified in Specimen by Culture
64
31
22.05
85.40
2.2
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
332
1117
4.02
85.28
3.8
2.3
umol/l
12.4
13.7
2.49
324
1036
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
630
3276
3.69
81.82
18.2
6.0
mmol/l
1.2
1.2
2.46
608
2988
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
627
3265
3.66
80.93
4.4
2.3
nmol/l
81.4
75.9
5.30
601
2969
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
98
113
9.55
79.32
2.3
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
664
3625
3.70
78.65
18.2
6.5
mmol/l
1.2
1.2
1.19
588
3069
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
90
96
10.24
77.14
2.3
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
83
79
11.41
77.03
2.3
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
224
608
4.50
76.33
9.5
4.6
%
0.2
0.1
0.19
104
171
(3027945) Reticulocytes/100 erythrocytes in Blood
251
753
4.16
74.69
6.5
2.8
%
2.0
1.8
2.28
237
679
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
99
126
8.65
74.04
1.8
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
589
3061
3.40
73.88
11.4
4.7
g/l
34.7
36.2
6.51
573
2875
(44806118)
85
90
10.27
73.19
1.9
1.6
—
—
—
0
0
(44790049)
85
90
10.27
73.19
1.9
1.6
—
—
—
0
0
(44790047)
85
90
10.27
73.19
1.9
1.6
—
—
—
0
0
(44790048)
85
90
10.27
73.19
1.9
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
207
545
4.57
73.15
5.1
2.6
e9/l
78.3
72.7
0.95
170
402
(3018418) pH of Serum or Plasma
463
2096
3.34
72.99
9.5
3.7
ph
7.4
7.4
0.06
100
405
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
678
3890
3.54
71.11
12.3
6.0
umol/l
9.7
11.0
3.02
665
3684
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
107
157
7.55
70.83
3.1
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
76
72
11.38
70.67
4.1
3.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
246
764
3.99
69.29
3.4
2.0
nmol/l
322.2
370.5
2.93
229
707
(3025159) Blasts/100 leukocytes in Blood
209
577
4.35
69.19
9.7
4.7
%
0.0
0.1
0.59
90
143
(3021589) Normoblasts [#/volume] in Blood
640
3605
3.33
67.95
25.9
8.8
e9/l
0.0
0.0
0.07
576
2929
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
100
144
7.64
67.24
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
100
144
7.64
67.24
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
390
1661
3.27
66.90
2.2
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
312
1161
3.50
66.73
10.3
3.8
mmol/l
0.8
0.8
0.94
301
1091
(3042111) Morphology [Interpretation] in Bone marrow Narrative
84
104
8.76
64.08
2.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
70
68
11.03
63.91
2.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
70
68
11.03
63.91
2.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
70
68
11.03
63.91
2.3
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
138
290
5.39
63.52
2.7
1.2
u/l
41.5
38.5
0.88
127
257
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
854
5904
5.08
63.20
21.3
7.0
u/l
83.0
79.3
1.68
838
5543
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
127
251
5.68
62.53
3.3
2.1
ug/l
1.2
2.6
0.64
121
234
(3013707) Erythrocyte sedimentation rate by Westergren method
846
5841
4.81
61.91
12.9
3.9
mm/h
13.0
10.9
3.81
826
5411
(3037756) Immunofixation for Serum or Plasma
91
130
7.63
61.52
1.7
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
141
312
5.13
61.10
2.0
1.4
u/ml
5.8
7.6
—
8
6
(3037692) Legionella sp identified in Specimen by Organism specific culture
48
27
18.66
59.71
1.5
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
126
258
5.47
59.59
2.7
2.0
g/l
1.4
1.5
0.52
107
230
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
402
1851
3.02
58.68
3.5
2.2
mg/l
3.3
3.0
1.88
381
1593
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
75
90
8.96
58.58
3.8
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
83
113
7.95
58.46
5.5
3.1
%
1.3
1.3
0.00
76
93
(3045142) Bone marrow Pathology biopsy report
70
77
9.73
58.43
1.8
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
293
1131
3.29
58.01
1.9
1.3
titre
555.9
544.6
0.04
58
236
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
75
92
8.76
57.56
3.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
75
92
8.76
57.56
3.8
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
74
90
8.83
57.17
3.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
74
90
8.83
57.17
3.8
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
74
91
8.73
56.67
3.8
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
122
257
5.29
55.79
5.1
2.0
g/l
3.1
3.7
2.41
90
198
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
122
257
5.29
55.79
5.1
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
122
257
5.29
55.79
5.1
2.0
g/l
7.2
7.4
0.50
92
210
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
242
5.42
55.60
5.2
2.1
g/l
3.0
3.1
0.42
90
203
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
113
223
5.61
55.55
5.1
2.2
g/l
0.8
0.6
0.28
102
208
(3048689) Calprotectin [Mass/mass] in Stool
284
1101
3.24
55.53
2.7
2.4
ug/g
158.8
123.1
0.79
235
877
(3033658) Prothrombin time (PT) actual/Normal
404
1931
2.89
54.14
7.3
3.9
%
95.9
92.8
1.71
395
1882
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
90
147
6.65
53.66
2.2
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
687
4356
3.03
53.20
12.2
4.7
mmol/l
6.6
6.6
0.18
663
4028
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
46
30
16.06
53.15
2.8
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
408
1988
2.83
52.34
5.9
2.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
45
29
16.23
52.30
2.8
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
45
29
16.23
52.30
2.8
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
49
37
13.90
52.26
2.7
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
49
37
13.90
52.26
2.7
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
49
37
13.90
52.26
2.7
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
49
37
13.90
52.26
2.7
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
411
2021
2.81
51.66
6.0
3.0
e6/l
0.2
0.4
1.71
341
1506
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
104
204
5.60
51.37
5.0
2.2
g/l
0.0
0.0
0.33
96
195
(3052851) Hemolysis interference index of Serum or Plasma
108
224
5.31
50.12
3.3
3.0
—
—
—
0
0
(3026782) Osmolality of Urine
323
1424
2.91
49.57
5.6
2.5
mosm/kgh2o
511.2
552.5
2.93
301
1228
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
97
185
5.72
49.35
6.8
3.6
mg/l
27.0
27.9
0.06
77
149
(3034860) Kappa light chains.free [Mass/volume] in Serum
97
185
5.72
49.35
6.9
3.6
mg/l
38.7
82.1
0.67
76
150
(3020779) Urea [Moles/volume] in Serum or Plasma
188
610
3.59
48.34
15.6
7.2
mmol/l
10.1
8.2
2.91
180
584
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
94
179
5.71
47.87
6.9
3.6
ratio
2.5
1.8
—
7
23
(40760888) Immunoglobulin light chains.free panel - Serum
83
141
6.35
47.53
6.6
3.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
484
2666
2.65
47.48
7.0
3.5
e6/l
46.0
100.0
1.45
376
1834
(3017143) Hepatitis C virus Ab [Presence] in Serum
255
1007
3.09
47.47
2.0
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
89
165
5.84
46.61
1.6
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
378
1857
2.71
46.59
13.4
4.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
330
1519
2.79
46.15
5.4
2.4
e6/l
3.9
5.9
3.63
305
1334
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
238
4.93
45.70
5.5
2.1
g/l
7.5
10.3
7.73
92
217
(3018677) aPTT in Platelet poor plasma by Coagulation assay
266
1099
2.97
45.47
4.4
2.4
s
29.5
29.7
0.18
260
1070
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
106
235
4.95
45.45
7.2
3.8
g/l
3.6
3.5
0.16
101
225
(3002582) Erythrocytes [#/volume] in Urine
422
2218
2.61
44.98
6.3
3.1
e6/l
23.8
54.8
2.15
352
1689
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
42
32
13.68
44.49
2.4
3.1
u/ml
157623.7
1691.8
—
6
5
(3001122) Ferritin [Mass/volume] in Serum or Plasma
583
3593
2.59
44.11
5.0
2.7
ug/l
173.7
108.5
2.84
565
3344
(3024891) Influenza virus A+B Ag [Presence] in Specimen
104
233
4.88
44.01
1.3
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
57
70
8.59
43.56
1.5
1.3
u/ml
0.3
0.9
0.43
37
31
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
472
2649
2.54
43.40
5.9
3.2
u/l
35.6
31.3
0.65
457
2526
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
299
1358
2.75
42.37
2.0
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
361
1806
2.60
42.03
4.9
2.9
ng/l
1566.2
1016.8
0.92
332
1512
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
34
20
17.59
41.21
1.6
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
353
1771
2.57
40.59
2.9
1.9
mg/l
1.4
1.1
0.67
290
1334
(3000492) Spirometry study
213
824
3.04
40.51
2.9
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
722
5045
2.74
40.32
8.4
4.1
e6/l
172.5
2479.1
—
8
71
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
94
208
4.90
40.30
2.1
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
79
150
5.65
40.25
1.6
1.5
u/ml
91.7
103.2
0.58
23
32
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
139
417
3.73
39.82
1.9
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
93
207
4.87
39.58
5.3
2.1
g/l
39.0
38.5
0.32
87
188
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
220
877
2.96
39.57
4.2
3.1
umol/l
6.1
7.1
0.57
199
766
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
81
161
5.40
39.25
9.4
3.7
%
57.2
56.9
0.04
81
161
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
88
189
5.03
39.05
5.5
2.2
g/l
0.0
0.0
0.49
81
180
(3000991) Gas panel - Venous blood
178
634
3.22
38.91
19.6
8.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
87
187
5.02
38.56
5.5
2.2
g/l
0.0
0.0
0.00
81
179
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
37
30
12.79
37.71
1.6
1.3
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
44
8
57.53
37.65
1.8
2.6
ug/g
224.4
139.9
—
34
8
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
28
13
22.16
37.57
2.2
3.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
126
368
3.79
37.45
2.4
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
356
1876
2.43
35.97
6.2
2.5
umol/l
2567.2
5893.4
1.06
331
1654
(3044640) Blood type and Crossmatch panel - Blood
415
2359
2.34
35.06
4.6
2.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
390
2159
2.36
35.03
3.4
2.1
u/l
139.2
218.5
1.24
376
2036
(3021879) Hepatitis B virus core Ab [Presence] in Serum
172
638
3.07
34.85
1.6
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
142
470
3.37
34.80
1.8
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
55
84
6.89
34.77
4.0
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
735
5356
2.59
34.55
8.4
4.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
40
42
9.89
34.36
1.5
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
81
181
4.80
34.23
1.5
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
181
698
2.96
34.19
14.6
4.6
mmol/l
1.7
2.0
0.54
158
551
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
36
33
11.30
33.93
1.6
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
91
227
4.32
33.50
1.6
1.5
ug/g
318.4
300.5
0.33
57
139
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
24
10
24.59
33.48
1.3
1.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
165
613
3.04
33.25
17.2
7.5
mmol/l
1.3
1.3
0.10
155
583
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
44
9.44
33.20
2.9
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
92
234
4.24
33.01
4.8
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
41
47
9.07
32.99
1.4
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
37
10.36
32.88
3.0
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
34
30
11.71
32.83
1.8
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
53
83
6.70
32.71
6.4
3.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
68
136
5.31
32.66
1.5
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
154
556
3.11
32.58
5.7
4.1
ng/l
84.9
78.0
0.48
147
499
(3015171) Extractable nuclear Ab [Units/volume] in Serum
110
323
3.72
32.31
1.5
1.2
u/ml
1.8
1.5
0.10
21
21
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
43
54
8.29
32.19
2.8
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
71
151
5.00
31.79
2.7
2.4
g/l
126.9
130.1
0.25
29
115
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
43
55
8.14
31.71
2.0
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
467
2875
2.22
31.63
2.6
1.9
pmol/l
94.8
96.5
0.34
292
1456
(3003396) Base excess in Arterial blood by calculation
179
721
2.82
31.00
15.9
8.8
mmol/l
1.0
1.3
0.33
142
575
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
91
241
4.07
30.90
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
52
85
6.41
30.79
1.5
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
36
38
9.80
30.77
3.1
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
448
2738
2.19
30.61
10.8
7.6
inr
1.1
1.2
0.35
130
828
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
78
187
4.45
30.18
8.8
4.4
u/ml
0.4
0.4
0.04
54
94
(3027801) Oxygen [Partial pressure] in Arterial blood
178
725
2.79
30.13
15.9
8.7
kpa
11.7
12.6
1.51
166
697
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
178
725
2.79
30.13
15.9
8.7
kpa
5.1
5.2
0.35
166
695
(3048929) Epstein Barr virus Ab [Presence] in Serum
104
308
3.67
30.11
1.6
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
74
174
4.52
29.33
1.5
1.2
u/ml
3.2
7.4
0.27
15
12
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
94
265
3.82
29.22
2.7
2.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
73
172
4.51
28.85
1.6
1.4
u/ml
203.8
243.3
0.67
56
97
(3019309) Folate [Moles/volume] in Red Blood Cells
243
1175
2.43
28.77
2.0
1.7
nmol/l
1295.5
1215.2
0.62
205
888
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
136
491
3.06
28.61
11.0
4.1
mmol/l
1.5
1.7
0.18
107
360
(3016502) Oxygen saturation in Arterial blood
161
640
2.82
28.44
17.1
9.3
%
95.4
95.9
0.58
150
621
(3026008) Bacteria identified in Urine by Culture
371
2158
2.17
28.16
4.7
2.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
248
1221
2.39
28.13
4.1
2.7
e6/l
1.2
1.1
0.17
146
668
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
57
112
5.35
27.88
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
138
510
2.99
27.83
11.0
4.1
ph
7.4
7.4
0.39
20
54
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
139
516
2.98
27.81
11.1
4.0
kpa
5.0
5.1
0.56
131
484
(4010399)
147
564
2.90
27.70
1.7
1.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
36
44
8.46
27.51
1.8
1.4
u/l
4.6
8.0
1.22
31
37
(3036489) Thrombin time
99
301
3.55
27.50
4.7
3.1
s
21.3
21.4
0.05
94
272
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
91
262
3.73
27.42
4.2
1.9
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
27
22
12.60
27.32
5.4
4.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
323
1797
2.20
27.26
4.1
2.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
23
14
16.81
27.24
2.0
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
562
3861
2.10
27.14
7.9
4.6
estimate
0.0
0.0
0.50
133
754
(3021960) Folate [Moles/volume] in Serum or Plasma
300
1624
2.23
27.07
2.0
1.5
nmol/l
22.2
21.4
0.33
277
1394
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
31
32
9.98
26.89
2.6
2.3
ug/l
61.6
103.9
0.89
31
32
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
88
251
3.76
26.87
1.5
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
564
3895
2.09
26.66
6.2
3.4
estimate
0.0
0.0
0.50
129
724
(3035350) Ketones [Presence] in Urine by Test strip
559
3850
2.08
26.59
6.2
3.4
estimate
0.0
0.0
0.00
129
738
(21494434) Karyotype in Bone marrow
41
61
6.98
26.50
1.2
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
407
2499
2.09
26.41
5.0
3.2
mmol/l
2.3
2.4
4.01
367
2212
(3037121) Protein [Mass/volume] in Urine
92
274
3.61
26.35
4.4
4.1
g/l
0.5
0.3
0.89
56
126
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
233
1151
2.35
26.00
4.3
2.8
e6/l
2.7
2.9
0.10
132
602
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
81
224
3.86
25.84
1.5
1.2
u/ml
2.0
2.5
0.30
16
23
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
81
227
3.81
25.35
1.5
1.2
u/ml
12.0
9.9
0.07
18
37
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
924
8028
5.14
24.44
47.0
12.1
mg/l
19.0
22.2
3.02
861
6173
(3017354) Segmented neutrophils/100 leukocytes in Blood
42
70
6.23
24.37
4.5
3.0
%
61.1
53.3
1.19
36
47
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
382
2344
2.05
24.34
3.8
2.4
u/l
54.6
56.0
0.38
371
2174
(3019060) Gas panel - Arterial blood
113
402
3.05
24.26
11.8
6.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
83
244
3.63
24.21
1.5
1.2
u/ml
8.6
20.7
0.41
11
14
(3007566) Smooth muscle Ab [Titer] in Serum
76
211
3.83
24.09
1.3
1.2
titre
58.9
80.0
—
9
20
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
29
32
9.31
23.94
1.8
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
29
32
9.31
23.94
1.8
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
30
35
8.82
23.75
1.1
1.1
—
—
—
0
0
(4035726)
154
654
2.61
23.67
2.0
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
81
239
3.61
23.49
1.7
1.6
iu/ml
0.9
0.1
0.44
23
41
(3039162) Centromere protein B Ab [Units/volume] in Serum
52
110
4.94
23.38
1.6
1.3
u/ml
32.2
62.8
—
8
6
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
114
417
2.97
23.28
18.9
4.8
mmol/l
24.3
24.2
0.05
100
383
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
54
120
4.71
22.90
1.4
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
25
24
10.67
22.75
1.4
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
186
880
2.38
22.62
1.6
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
26
27
9.87
22.41
1.6
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
305
1771
2.06
22.22
5.3
3.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
37
60
6.37
22.04
3.6
2.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
142
600
2.60
21.98
18.7
9.2
g/l
115.8
121.3
2.04
135
581
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
69
191
3.82
21.95
1.5
1.2
u/ml
18.4
39.3
0.64
19
17
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
67
182
3.88
21.89
2.3
1.4
mmol/l
3.6
3.7
0.05
62
171
(3016018) Differential panel - Cerebral spinal fluid
42
78
5.59
21.82
2.1
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
77
232
3.52
21.62
3.5
2.1
ug/l
285.4
313.8
0.08
68
218
(3000093) Morphology [Interpretation] in Blood Narrative
39
69
5.85
21.31
1.4
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
157
706
2.46
21.28
2.9
2.5
u/l
32.9
108.9
0.57
133
590
(40768797) Stomach Pathology biopsy report
212
1088
2.22
21.16
1.3
1.2
—
—
—
0
0
(4015189)
18
11
16.66
21.16
2.3
3.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
18
11
16.66
21.16
1.3
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
405
2631
1.93
21.15
5.5
3.2
ng/l
55.4
39.6
0.29
275
1671
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
50
112
4.65
21.00
1.4
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
119
472
2.74
20.84
3.9
2.7
ng/l
192.7
164.3
0.24
102
426
(3051651) Icteric interference index of Serum or Plasma
34
54
6.49
20.66
3.9
3.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
95
337
3.02
20.42
15.7
10.4
mmol/l
24.3
24.4
0.22
86
317
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
40
76
5.45
20.28
1.3
1.2
u/l
162.6
66.9
0.43
31
56
(40768795) Lymph node Pathology biopsy report
38
70
5.61
19.91
1.7
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
59
157
3.94
19.83
2.5
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
72
221
3.44
19.63
1.3
1.3
—
1216.3
—
0
8
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
507
3601
1.87
19.61
7.2
3.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
38
71
5.53
19.61
1.3
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
38
73
5.38
19.03
3.8
3.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
50
122
4.27
18.87
1.1
1.1
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
18
0
+∞
18.81
1.7
0.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
32
53
6.21
18.67
2.8
2.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
36
67
5.54
18.66
1.7
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
24
29
8.46
18.44
1.6
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
24
29
8.46
18.44
1.6
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
16
11
14.78
17.65
1.3
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
233
1320
2.01
17.59
4.9
3.4
ng/l
470.9
386.7
0.10
163
936
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
90
337
2.84
17.52
23.7
12.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
26
37
7.19
17.45
1.2
1.6
—
2010630.0
—
0
5
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
82
294
2.96
17.26
6.9
4.1
%
53.7
50.0
0.65
82
289
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
60
178
3.53
17.23
2.5
1.5
e6/l
59.2
198.9
1.43
52
138
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
60
178
3.53
17.23
2.5
1.5
e6/l
6.5
15.1
0.61
50
135
(3019550) Sodium [Moles/volume] in Serum or Plasma
910
8116
3.37
16.99
44.1
13.5
mmol/l
139.4
139.7
3.61
904
7897
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
23
30
7.83
16.61
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
96
384
2.67
16.46
13.7
4.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
125
567
2.39
16.44
2.8
2.4
au/ml
4.5
15.3
—
5
32
(3023199) Leukocytes [#/volume] in Pleural fluid
30
53
5.81
16.41
1.7
1.3
e6/l
1888.3
1933.4
0.02
25
35
(3023103) Potassium [Moles/volume] in Serum or Plasma
910
8143
3.30
16.34
45.0
13.5
mmol/l
3.9
3.9
0.93
903
7907
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
34
68
5.15
16.30
1.4
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
44
110
4.14
16.09
1.5
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
249
1484
1.92
16.03
1.8
1.6
pmol/l
30736423.6
30208757.8
0.01
231
1248
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
114
504
2.43
15.86
3.3
3.3
pmol/l
4.2
4.7
4.56
106
443
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
30
55
5.60
15.79
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
48
5.98
15.78
1.4
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
60
190
3.30
15.57
4.1
3.6
mmol/l
24.5
25.0
0.38
55
163
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
37
84
4.54
15.30
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
36
80
4.64
15.28
1.2
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
19
22
8.79
15.05
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
49
139
3.66
15.05
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
72
261
2.90
14.86
8.3
5.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
28
51
5.63
14.84
1.1
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
239
1438
1.88
14.80
1.4
1.3
iu/ml
18.7
30.7
1.99
70
457
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
232
1384
1.89
14.74
1.3
1.3
u/ml
4.9
11.6
1.72
78
550
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
29
55
5.41
14.73
4.8
2.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
20
9.15
14.69
1.2
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
23
8.41
14.54
1.2
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
23
35
6.71
14.52
2.7
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
23
35
6.71
14.52
2.7
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
52
158
3.42
14.41
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
36
84
4.41
14.39
3.7
1.7
pg
32.6
32.7
0.03
36
84
(3028308) Erythrocytes [#/volume] in Pleural fluid
27
49
5.64
14.36
1.6
1.3
e6/l
47189.3
15462.6
0.60
14
27
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
21
8.72
14.16
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
433
3132
1.70
14.08
2.6
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
140
711
2.13
13.96
5.1
3.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
17
19
9.09
13.80
1.4
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
26
48
5.54
13.59
1.2
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
311
2071
1.74
13.56
7.7
3.6
estimate
0.0
0.0
1.08
128
741
(3017732) Neutrophils [#/volume] in Blood
111
520
2.28
13.49
3.0
2.8
e9/l
4.2
4.1
0.10
81
430
(4027681)
26
49
5.43
13.30
1.2
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
91
393
2.45
13.28
17.2
9.1
mmol/l
25.2
24.8
0.49
83
368
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
23
7.96
13.18
1.2
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
25
46
5.55
13.11
1.7
1.5
u/l
2.3
4.0
0.37
15
22
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
32
74
4.44
12.95
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
37
96
3.97
12.90
1.7
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
54
181
3.10
12.78
1.7
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
20
30
6.79
12.78
1.1
1.1
miu/ml
1315.9
1642.6
0.46
20
30
(40768443) Skin Pathology biopsy report
78
319
2.57
12.77
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
696
5795
1.73
12.66
4.8
3.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
13
11
11.97
12.65
1.1
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
44
5.57
12.63
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
40
112
3.68
12.54
1.3
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
35
89
4.04
12.54
1.2
1.4
pmol/l
732.8
349.6
0.54
29
71
(3009214) Lutropin [Units/volume] in Serum or Plasma
72
286
2.64
12.50
1.9
1.6
u/l
10.1
9.7
0.07
60
228
(3030313) Adrenal Ab [Titer] in Serum
17
7
24.67
12.49
2.2
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
27
56
4.93
12.43
1.4
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
20
31
6.57
12.40
3.3
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
17
22
7.85
12.31
1.2
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
305
2065
1.70
12.30
1.4
1.4
u/ml
0.7
1.6
2.55
54
543
(3002385) Erythrocyte distribution width [Ratio]
798
6939
1.89
12.25
47.2
14.9
%
14.1
13.5
15.56
792
6800
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
21
35
6.11
12.16
1.8
1.1
ug/l
20.4
269.7
0.49
21
28
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
34
88
3.97
11.90
1.3
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
12
10
12.14
11.76
5.3
5.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
325
2261
1.66
11.71
4.3
3.2
mmol/l
7.0
7.8
2.33
294
1933
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
837
7427
2.00
11.61
30.8
11.0
ml/min/173m2
85.1
85.6
0.28
773
6032
(3000475) Leukocytes [#/volume] in Synovial fluid
48
159
3.13
11.60
2.5
1.7
e6/l
24719.1
15326.9
0.32
38
117
(40768446) Kidney Pathology biopsy report
18
27
6.78
11.49
1.9
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
17
24
7.19
11.44
2.4
1.7
—
—
—
0
0
(4034850)
63
245
2.68
11.41
15.2
8.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
29
69
4.30
11.33
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
29
69
4.30
11.33
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
29
69
4.30
11.33
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
65
258
2.63
11.31
1.5
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
111
558
2.12
11.30
7.3
3.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
70
4.24
11.13
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
42
5.34
11.10
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
42
5.34
11.10
1.1
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
42
133
3.26
10.94
4.9
2.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
34
94
3.71
10.87
2.6
2.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
28
68
4.21
10.67
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
28
68
4.21
10.67
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
28
68
4.21
10.67
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
44
146
3.11
10.62
6.8
3.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
203
1277
1.75
10.46
3.3
2.9
mmol/l
2.5
2.4
0.41
178
1127
(40761539) Cells [Type] in Urine sediment by Light microscopy
14
18
7.88
10.16
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
26
62
4.28
10.14
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
33
94
3.60
10.12
1.3
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
920
8556
2.85
10.11
27.3
9.5
u/l
27.5
26.5
1.05
910
8284
(3021788) Differential panel - Synovial fluid
38
119
3.28
10.09
2.1
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
160
948
1.83
10.07
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
32
90
3.64
9.99
3.6
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
59
4.32
9.88
1.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
63
264
2.48
9.82
1.5
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
35
106
3.39
9.79
2.0
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
37
117
3.25
9.68
1.9
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
63
266
2.46
9.67
1.5
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
27
69
4.00
9.63
1.1
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
11
10.10
9.56
4.5
6.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
62
262
2.46
9.50
1.5
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
396
3003
1.54
9.44
7.1
3.5
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
9
0
+∞
9.39
1.1
0.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
12
14
8.67
9.36
1.4
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
12
14
8.67
9.36
1.4
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
12
14
8.67
9.36
1.4
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
38
125
3.12
9.33
4.3
3.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
21
45
4.75
9.33
1.1
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
17
30
5.75
9.30
1.5
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
50
4.48
9.12
1.4
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
128
732
1.86
8.99
1.3
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
25
64
3.98
8.91
1.1
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
13
18
7.31
8.86
1.3
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
20
43
4.73
8.85
1.7
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
132
766
1.84
8.84
21.7
20.0
inr
1.3
1.2
—
8
118
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
723
6303
1.60
8.75
5.4
4.0
pmol/l
14.9
14.6
2.25
687
5800
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
41
147
2.87
8.68
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
36
5.08
8.64
1.7
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
260
1824
1.58
8.59
1.9
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
279
1993
1.56
8.51
4.5
3.2
mg/l
1540.6
226.7
1.85
180
1260
(3002523) Influenza virus A Ag [Presence] in Specimen
44
166
2.73
8.49
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
33
106
3.19
8.44
1.1
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
40
144
2.86
8.42
1.4
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
32
102
3.21
8.29
1.1
1.3
nmol/l
—
—
—
0
0
(3048879) Bone marrow aspiration report
10
11
9.18
8.10
1.2
2.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
107
597
1.89
8.09
2.8
2.3
ml/min/173m2
65.2
71.6
0.64
47
234
(3003740) Influenza virus B Ag [Presence] in Specimen
43
165
2.68
8.04
1.2
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
27
5.63
8.04
1.3
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
11
5
22.23
8.02
1.5
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
12
17
7.14
8.01
2.7
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
43
4.49
7.92
5.3
3.0
—
—
—
0
0
(3010421) pH of Blood
44
174
2.60
7.76
7.3
3.0
ph
7.4
7.4
0.17
39
145
(3013637) Mi-2 Ab [Presence] in Serum
13
21
6.26
7.72
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
13
21
6.26
7.72
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
13
21
6.26
7.72
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
13
21
6.26
7.72
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
907
8498
2.24
7.69
33.2
11.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
11
6
18.52
7.61
1.1
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
636
5460
1.49
7.61
5.3
3.1
u/l
59.2
44.7
2.67
614
5161
(3012501) Base excess in Blood by calculation
39
148
2.70
7.47
7.3
3.1
mmol/l
2.2
2.7
0.62
29
99
(3012441) Differential panel - Pleural fluid
21
54
3.95
7.46
2.0
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
19
46
4.19
7.30
1.3
1.1
u/l
1.0
1.1
—
7
24
(40768806) Pleura Pathology biopsy report
20
52
3.91
7.01
2.0
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
36
136
2.71
6.96
5.7
2.6
%
16.6
16.5
0.08
24
72
(3044889) 12 lead EKG panel
621
5351
1.46
6.94
4.6
3.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
77
3.31
6.87
2.0
1.6
%
61.2
57.3
0.19
18
60
(3020682) Albumin/Creatinine [Ratio] in Urine
281
2090
1.49
6.87
5.3
3.9
mg/mmol
29.0
9.1
2.30
187
1316
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
67
338
2.06
6.78
2.7
2.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
14
7.21
6.71
1.3
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
9
12.35
6.59
1.9
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
30
106
2.89
6.57
1.4
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
809
7405
1.59
6.33
6.3
4.7
mu/l
1.9
2.2
0.68
781
6853
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29
103
2.87
6.30
2.4
3.2
nmol/l
24.9
22.9
0.30
29
97
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
25
82
3.10
6.23
2.7
4.5
u/ml
53.6
94.9
—
7
25
(3041096) Erythrocytes [Presence] in Urine by Automated
286
2170
1.45
6.21
6.2
3.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
11
19
5.85
6.11
5.6
3.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
15
35
4.34
6.04
1.2
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
23
5.27
6.02
1.6
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
53
259
2.11
5.85
19.5
7.3
%
1.6
1.6
0.19
48
244
(3024471) HLA-A [Type]
11
20
5.55
5.81
1.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
33
132
2.55
5.75
1.8
1.1
iu/ml
62.5
3541.9
0.50
12
36
(1761868) Lipid panel - Serum or Plasma
231
3028
0.69
5.69
3.2
2.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
85
495
1.79
5.63
1.9
1.5
iu/l
21.1
25.9
0.77
75
417
(3019150) Specific gravity of Urine by Refractometry
230
1707
1.46
5.53
6.3
3.6
kg/l
1.0
1.0
0.29
20
227
(3024928) Oxygen saturation in Venous blood
37
160
2.37
5.48
30.5
4.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
8
5
16.12
5.41
3.8
6.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
8
5
16.12
5.41
3.6
6.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
31
124
2.55
5.41
1.8
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
8
11.34
5.29
1.1
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
8
11.34
5.29
1.1
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
26
4.66
5.27
2.4
2.7
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
5.21
1.4
0.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
18
54
3.38
5.18
3.8
2.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
43
204
2.16
5.15
23.8
8.8
mmol/l
1.6
1.2
0.97
37
177
(3000012) Reticulocyte production index
15
40
3.79
5.10
1.6
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
31
4.24
5.10
1.5
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
19
5.31
5.05
1.1
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
9
9
10.08
5.03
3.8
1.4
umol/l
40.2
38.0
—
9
9
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
9
9
10.08
5.03
1.6
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
36
3.93
5.00
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
86
526
1.70
4.82
2.9
2.3
nmol/l
13.7
12.8
0.42
73
472
(3045414) Leukocytes [Presence] in Urine
58
315
1.90
4.82
2.5
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
15
42
3.61
4.78
1.2
1.3
nmol/l
121.8
152.5
1.06
15
42
(3019832) Treponema pallidum Ab [Presence] in Serum
134
916
1.54
4.78
1.7
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
105
680
1.61
4.72
3.2
4.1
ug/l
18.6
25.5
0.14
80
550
(3025018) Bordetella pertussis Ab [Titer] in Serum
20
69
2.94
4.62
1.4
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
11
8.25
4.56
5.9
5.9
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
11
8.25
4.56
1.2
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
54
937
0.55
4.44
1.3
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
12
7.56
4.36
1.7
1.3
—
—
—
0
0
(4268621)
23
89
2.62
4.33
2.3
2.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
22
4.58
4.31
2.8
1.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
22
4.58
4.31
1.5
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
31
3.91
4.26
4.8
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
46
825
0.54
4.24
1.6
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
55
308
1.83
4.19
1.3
1.3
miu/ml
241.2
246.2
0.03
21
152
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
30
134
2.28
4.19
1.2
1.2
u/ml
5.9
5.3
—
10
55
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
13
6.98
4.17
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
104
693
1.56
4.16
9.3
3.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
23
4.38
4.09
1.1
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
9
14
6.48
3.99
1.3
1.0
mg/g
6.2
5.6
—
9
14
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
14
6.48
3.99
2.0
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
9
14
6.48
3.99
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
28
3.96
3.98
2.9
2.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
15
6.05
3.82
1.3
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
34
3.56
3.77
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
38
195
1.99
3.77
1.1
1.1
u/ml
6.9
7.1
0.02
29
116
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
5
12.06
3.76
4.8
6.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
80
516
1.60
3.69
2.2
1.8
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
12
6.71
3.68
2.0
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
16
5.67
3.66
1.4
2.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
20
79
2.56
3.65
3.5
2.2
mg/l
25.9
24.7
—
7
23
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
47
263
1.83
3.62
3.3
2.9
u/ml
162.6
1297.4
0.97
42
222
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
9
7.82
3.56
1.9
3.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
34
172
2.01
3.52
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
75
482
1.60
3.52
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
58
349
1.70
3.51
1.1
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
6
10.05
3.50
11.0
5.5
mmol/l
4.5
6.9
—
6
6
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
95
647
1.52
3.47
1.6
1.2
iu/ml
57.9
157.5
4.65
45
259
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
574
0.51
3.43
1.5
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
64
2.69
3.41
1.9
1.4
e6/l
193562.1
150033.0
0.08
12
45
(3019225) pH of Specimen
98
675
1.50
3.40
9.8
3.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
82
544
1.55
3.37
2.5
2.2
ug/l
5.4
6.6
0.51
73
483
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
32
3.47
3.34
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
28
135
2.11
3.30
1.2
1.2
u/ml
1.4
3.6
—
10
45
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
257
2094
1.31
3.30
1.6
1.7
mmol/l
1.5
1.4
0.59
235
1789
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
7
8.62
3.26
1.3
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
103
2.26
3.24
2.3
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
19
4.77
3.24
7.3
8.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
19
4.77
3.24
1.6
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
15
5.37
3.19
1.8
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
15
5.37
3.19
1.3
1.2
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
8
15
5.37
3.19
1.9
3.3
mmol/l
19.9
20.6
—
8
15
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
45
261
1.76
3.12
1.2
1.1
u/ml
29.9
6.6
—
7
42
(3008401) Mugwort IgE Ab [Units/volume] in Serum
35
188
1.89
3.09
1.1
1.1
u/ml
0.3
0.7
1.53
22
98
(3025130) Human papilloma virus identified in Specimen
27
133
2.06
3.03
2.1
1.8
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
5
10.04
2.98
2.0
6.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
13
5.42
2.87
1.3
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
9
6.70
2.87
1.5
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
9
6.70
2.87
1.3
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
34
187
1.85
2.82
1.2
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
14
5.03
2.73
1.4
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
14
5.03
2.73
1.3
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
19
85
2.26
2.71
1.2
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
10
6.03
2.70
3.2
3.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
34
190
1.82
2.69
2.5
2.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
19
4.24
2.68
1.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
19
4.24
2.68
8.1
8.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
91
651
1.44
2.64
2.3
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
15
61
2.48
2.63
22.4
5.3
%
10.7
11.4
0.29
15
61
(3032057) Clostridioides difficile [Presence] in Stool
7
15
4.69
2.60
5.9
2.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
33
186
1.80
2.56
1.2
1.1
u/ml
4.7
4.0
0.06
13
44
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
7
7.17
2.55
1.2
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
11
5.48
2.54
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
11
5.48
2.54
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
77
540
1.46
2.49
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
57
376
1.55
2.46
2.4
2.3
u/l
7866.9
3434.6
0.35
18
157
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
37
219
1.72
2.44
1.2
1.1
u/ml
0.8
2.4
1.46
23
107
(3007461) Platelets [#/volume] in Blood
930
9096
1.74
2.31
59.4
17.9
e9/l
248.4
256.1
2.22
924
8867
(3035933) Granulocytes/100 leukocytes in Blood
10
35
2.88
2.31
1.3
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
53
2.47
2.28
1.8
1.5
%
28.6
34.5
—
8
38
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
27
149
1.84
2.26
1.9
1.5
nmol/l
0.2
0.4
1.76
21
119
(3026361) Erythrocytes [#/volume] in Blood
930
9100
1.73
2.25
59.4
17.9
e12/l
4.4
4.5
10.60
919
8854
(3010813) Leukocytes [#/volume] in Blood
930
9102
1.72
2.22
59.5
17.9
e9/l
7.2
6.6
3.26
920
8851
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
9
5.58
2.21
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
57
386
1.51
2.21
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
322
0.49
2.21
1.2
1.4
—
—
—
0
0
(3013512) EKG study
239
2026
1.24
2.14
5.2
3.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
130
1.87
2.14
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
47
310
1.54
2.07
2.2
2.3
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
6
15
4.02
2.04
3.3
1.2
mmol/l
3.2
2.6
—
6
15
(3011288) Drugs identified in Urine by Screen method
41
264
1.58
2.01
3.3
3.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
132
1051
1.30
1.99
1.7
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
57
2.30
1.98
3.4
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
47
314
1.52
1.97
1.6
1.6
—
—
—
0
0
(44813793)
14
64
2.21
1.95
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
41
268
1.55
1.90
1.9
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
17
3.54
1.84
1.3
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
12
4.18
1.82
1.6
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
12
4.18
1.82
1.2
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
15
73
2.07
1.81
1.1
1.2
nmol/l
1.8
1.4
0.41
15
67
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
23
3.06
1.80
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
29
2.77
1.79
1.3
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
29
2.77
1.79
2.6
2.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
36
2.51
1.74
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
127
1.75
1.65
1.1
1.1
u/ml
1.6
6.2
1.70
11
50
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
34
222
1.55
1.61
2.3
1.7
nmol/l
43.1
38.3
0.58
34
217
(40768441) Liver Pathology biopsy report
14
70
2.01
1.59
1.1
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
15
3.34
1.52
10.2
9.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
45
0.00
1.50
0.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
28
2.51
1.45
1.9
2.2
—
—
—
0
0
(4306422)
21
125
1.70
1.44
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
81
1.87
1.40
3.8
2.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
24
150
1.62
1.39
3.6
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
51
376
1.38
1.35
2.1
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
45
325
1.40
1.34
5.3
3.3
—
—
—
0
0
(4024509)
11
54
2.05
1.33
1.6
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
127
1061
1.23
1.32
2.2
1.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
194
0.51
1.32
1.6
1.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
18
2.79
1.28
2.2
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
116
0.43
1.25
1.2
1.4
mmol/l
5.8
7.3
—
5
75
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
139
1.60
1.24
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
137
1163
1.21
1.23
2.3
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
54
409
1.34
1.23
2.1
2.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
54
410
1.34
1.21
2.1
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
54
411
1.33
1.19
2.1
2.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
19
117
1.64
1.18
1.0
1.1
u/ml
0.1
1.5
—
8
30
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
149
1.56
1.18
2.0
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
77
950
0.79
1.16
1.9
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
22
143
1.55
1.12
1.1
1.0
u/ml
10.3
4.8
0.33
13
52
(3009542) Hematocrit [Volume Fraction] of Blood
786
7625
1.17
1.10
41.8
13.0
%
39.3
40.1
2.72
615
5856
(3027944) Amphetamines [Presence] in Urine
53
408
1.32
1.10
1.7
2.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
28
194
1.46
1.07
1.4
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
123
1050
1.20
1.06
1.7
1.8
%
1.6
1.4
1.27
109
944
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
31
220
1.42
1.06
2.1
1.9
iu/l
3.1
4.9
1.12
11
74
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
324
0.67
1.05
2.0
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
22
2.28
1.03
2.6
3.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
61
1.81
0.98
1.2
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
72
874
0.81
0.96
13.4
6.1
—
—
—
0
0
(4281824)
14
85
1.66
0.94
1.4
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
64
520
1.25
0.91
1.1
1.0
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
6
31
1.94
0.84
2.0
2.6
mg/l
9.2
10.2
—
6
26
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
19
272
0.69
0.82
1.5
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
6
33
1.82
0.79
2.8
3.2
umol/l
23.6
31.1
—
6
24
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
48
1.67
0.79
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
43
341
1.27
0.77
1.7
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
22
157
1.41
0.77
3.7
3.8
mg/l
27.6
25.5
0.11
14
98
(3017569) Oxygen content in Arterial blood
6
34
1.77
0.76
1.5
4.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
57
469
1.23
0.75
4.2
2.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
735
7155
1.12
0.75
6.5
5.2
mmol/mol
39.4
39.1
0.38
699
6702
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
24
2.09
0.74
3.8
3.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
24
2.09
0.74
3.8
3.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
41
1.71
0.70
1.6
1.1
iu/ml
127.2
177.7
—
7
41
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
42
1.67
0.68
5.1
7.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
28
1.79
0.66
1.2
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
771
7861
0.90
0.61
4.8
4.2
mmol/l
4.6
4.8
2.39
739
7353
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
221
0.72
0.60
1.5
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
42
508
0.82
0.60
2.5
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
10
64
1.57
0.58
1.4
1.1
nmol/l
328.4
402.6
—
10
58
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
740
7554
0.91
0.58
4.5
3.7
mmol/l
1.4
1.3
4.64
705
7001
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
768
7826
0.91
0.58
4.7
4.1
mmol/l
1.5
1.5
1.25
730
7286
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
19
252
0.75
0.57
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
19
252
0.75
0.57
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
19
252
0.75
0.57
1.3
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
218
0.73
0.56
1.4
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
19
251
0.75
0.55
1.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
242
2269
1.09
0.53
1.6
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
67
1.50
0.49
1.7
1.6
g/l
0.9
1.1
—
10
67
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
39
462
0.84
0.47
1.7
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
48
1.46
0.47
1.1
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
120
0.66
0.45
1.1
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
787
7985
0.92
0.43
5.2
4.6
mmol/l
2.7
2.8
3.67
745
7423
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
57
1.41
0.42
1.9
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
16
0.00
0.41
0.0
2.1
—
7.9
—
0
10
(3000285) Sodium [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
2.2
—
2.7
—
0
9
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
106
0.66
0.39
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
158
0.76
0.37
1.3
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
17
136
1.25
0.33
1.4
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
47
1.28
0.32
6.0
1.8
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
17
137
1.25
0.32
4.9
5.3
umol/l
352.2
364.0
0.12
17
124
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
774
7644
1.07
0.31
5.0
4.1
mmol/l
5.9
5.8
0.73
741
7031
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
208
0.81
0.31
1.4
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
104
973
1.08
0.27
3.0
2.8
ug/l
0.6
0.7
0.51
78
587
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
95
888
1.08
0.26
4.5
4.3
%
31.1
32.0
0.37
80
604
(3050129) First trimester maternal screen panel - Serum or Plasma
26
299
0.87
0.26
1.5
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
202
0.84
0.25
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
170
1.18
0.24
6.5
4.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
201
0.84
0.24
1.4
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
88
1.25
0.22
2.4
2.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
172
1.17
0.22
3.2
2.4
ug/min
257.9
94.9
0.62
15
108
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
155
0.84
0.20
1.1
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
221
1.13
0.20
2.4
2.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
52
1.15
0.19
1.2
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
60
1.17
0.18
1.4
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
11
91
1.21
0.17
4.4
2.9
nmol/l
0.7
0.9
—
6
71
(4146454)
5
68
0.73
0.17
3.8
2.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
171
1655
1.04
0.16
4.1
4.4
ug/l
1.7
2.4
1.37
164
1502
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
160
1547
1.04
0.16
1.6
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
96
0.83
0.13
1.8
1.1
—
—
—
0
0
(4094501)
21
194
1.08
0.09
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
72
0.83
0.07
1.5
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
32
337
0.95
0.07
1.6
1.4
mg/l
3.0
3.1
0.03
24
237
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
101
0.99
0.00
1.3
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
133
1333
1.00
0.00
4.1
3.9
%
21.1
21.3
0.04
64
569
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
49
1.02
0.00
1.4
2.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4198724)
6
64
0.94
0.00
1.5
1.5
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
6
0.00
0.00
0.0
1.2
—
7.7
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
1500.8
—
0
6
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.8
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint D3_IMMUDEFANTIBODY and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFANTIBODY | 2.903 [2.37, 3.55] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.301 |
During the follow-up period (1.1.1998 — 31.12.2019), 305 out of 2102 females with D3_IMMUDEFANTIBODY died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFANTIBODY | 2.794 [2.15, 3.63] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 231 out of 1401 males with D3_IMMUDEFANTIBODY died.
Mortality risk
Mortality risk for people of age
years, who have D3_IMMUDEFANTIBODY.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.329% | 0.461% |
| 5 | 1.814% | 2.947% |
| 10 | 4.576% | 7.651% |
| 15 | 8.876% | 13.489% |
| 20 | 14.553% | 22.313% |
Relationships between endpoints
↥Index endpoint: D3_IMMUDEFANTIBODY – Immunodeficiency with predominantly antibody defects
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data